AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Averride M 1mg/500mg Tablet SR

Prescription Icon
Prescription Required

Marketer

Altrawell Biotech Pvt Ltd

Salt Composition

Glimepiride (1mg) + Metformin (500mg)

Overview Averride M 1mg/500mg Tablet SR

Diabex Duo 1mg/500mg Extended-Release Tablets are classified as antidiabetic medications. This dual-action formulation treats type 2 diabetes in adults by regulating blood glucose. Diabex Duo should be ingested with meals, consistently at the same time daily for optimal effectiveness. Dosage is determined by your physician and may adjust based on your blood sugar response. Continued use is crucial, even with controlled glucose levels; discontinuation without medical consultation risks elevated blood sugar, potentially leading to kidney complications, vision impairment, neuropathy, and limb loss. This medication complements a comprehensive diabetes management plan, including a balanced diet, regular physical activity, and weight management as directed by your doctor. Lifestyle choices significantly impact diabetes control. Hypoglycemia (low blood sugar) is the most frequent side effect, characterized by sweating, dizziness, headache, and tremors. Regular meals and readily available glucose sources (e.g., sugary snacks, juice) are essential to mitigate this risk. Alcohol consumption should be minimized due to its potential to lower blood sugar. Additional possible side effects include altered taste, nausea, diarrhea, abdominal discomfort, cephalalgia, and upper respiratory infections. Weight gain may occur. This medication is contraindicated for type 1 diabetes, diabetic ketoacidosis, and severe hepatic or renal impairment. Prior heart conditions should be disclosed to your doctor before initiating treatment. Pregnant or lactating individuals require medical consultation prior to use. Regular blood glucose monitoring is necessary, and your doctor may recommend blood tests to assess blood cell counts and liver function.

Uses of Averride M 1mg/500mg Tablet SR

Treatment of Type 2 diabetes mellitus

Major Benefits of Averride M 1mg/500mg Tablet SR:

Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Averride M 1mg/500mg Tablet SR whole; avoid chewing, crushing, or breaking it. Consume this extended-release tablet with a meal.

Common Side effects of Averride M 1mg/500mg Tablet SR:

  • Headache
  • Hypoglycemia (low blood glucose level)
  • Nausea
  • Diarrhea

How to use Averride M 1mg/500mg Tablet SR:

Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Averride M 1mg/500mg Tablet SR whole; do not crush, chew, or divide it. Consume this extended-release tablet with a meal.

How Averride M 1mg/500mg Tablet SR works:

Averride M 1mg/500mg Tablet SR is a combination of two antidiabetic medicines: Glimepiride and Metformin.Glimepiride is a sulfonylurea which works by increasing the amount of insulin released by the pancreas in order to lower the blood glucose. Metformin is a biguanide which works by lowering glucose production in the liver, delaying glucose absorption from intestines and increasing the body's sensitivity to insulin.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Combining Averride M 1mg/500mg SR tablets with alcohol is inadvisable due to safety concerns.

PregnancyPregnancyCONSULT YOUR DOCTOR

Use of Averride M 1mg/500mg SR tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the potential advantages against any risks before prescribing. Seek medical advice.

Breast feedingBreast feedingUNSAFE

Extended-release Averride M tablets (1mg/500mg) are contraindicated for breastfeeding mothers due to potential infant toxicity.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.

KidneyKidneyCAUTION

Patients with kidney impairment should exercise caution when using Averride M 1mg/500mg Tablet SR, potentially requiring dosage modification. Medical consultation is essential. Averride M 1mg/500mg Tablet SR is contraindicated in individuals with severe kidney disease. Close monitoring of renal function is recommended during treatment.

LiverLiverCAUTION

Patients with liver impairment should use Averride M 1mg/500mg SR tablets cautiously, potentially requiring dosage modification. Consultation with a physician is advised. For individuals with mild to moderate hepatic dysfunction, Averride M 1mg/500mg SR tablets are typically initiated at a reduced dosage; however, their use is contraindicated in those with severe liver disease.

What if you forget to take Averride M 1mg/500mg Tablet SR :

Should you forget a dose of Averride M 1mg/500mg Tablet SR, administer it at your earliest convenience. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing pattern. Avoid taking a double dose.

Facts to Know About Averride M 1mg/500mg Tablet SR

LabelValue
Potential for Dependence None.
Type of Medication Medication for diabetes

FAQs on Averride M 1mg/500mg Tablet SR

Store the medication in its original, tightly sealed container. Follow the storage instructions provided on the packaging or label. Discard any leftover medication. Prevent access by children, pets, and others.
Averride M 1mg/500mg Tablet SR carries a risk of lactic acidosis, a serious medical condition characterized by excessive blood lactic acid. This is also referred to as Metformin-associated lactic acidosis (MALA). While uncommon, this adverse reaction is more likely in individuals with pre-existing kidney impairment, the elderly, or those who consume significant quantities of alcohol. Symptoms can manifest as muscle aches or weakness, vertigo, fatigue, cold extremities, respiratory distress, nausea, emesis, abdominal discomfort, or bradycardia. Should any of these symptoms appear, discontinue Averride M 1mg/500mg Tablet SR use and seek immediate medical attention.
A single tablet of Averride M SR, containing 1mg glimepiride and 500mg metformin, manages type 2 diabetes mellitus in adults. This dual-action medication enhances glycemic control when combined with a suitable diet and physical activity. Glimepiride stimulates pancreatic insulin secretion, thus reducing blood glucose. Metformin simultaneously decreases hepatic glucose production and increases insulin responsiveness. This formulation is unsuitable for type 1 diabetes management.
Averride M 1mg/500mg Tablet SR may cause common side effects including low blood sugar (hypoglycemia), taste changes, nausea, abdominal discomfort, diarrhea, and headache. Rare but potentially serious adverse reactions such as lactic acidosis can occur. Prolonged treatment may result in vitamin B12 deficiency.
Prolonged Averride M 1mg/500mg SR tablet use can indeed lead to Vitamin B12 deficiency by hindering its gastrointestinal absorption. This deficiency, if left unaddressed, might result in anemia, neurological complications such as peripheral neuropathy (manifesting as tingling, numbness in extremities, and weakness), urinary dysfunction, cognitive changes, and ataxia. Therefore, preventative annual supplemental Vitamin B12 is recommended by some studies.
Averride M 1mg/500mg SR tablets can induce hypoglycemia, characterized by low blood sugar. Manifestations of low blood sugar include nausea, headache, irritability, hunger pangs, sweating, dizziness, tachycardia, and feelings of anxiety or tremor. The risk increases with skipped or delayed meals, alcohol consumption, excessive physical activity, or concomitant use of other antidiabetic medications. Therefore, consistent blood glucose monitoring is crucial. Carrying a readily available source of glucose, such as glucose tablets, honey, or fruit juice, is recommended.
Combining Averride M 1mg/500mg Tablet SR with alcohol is unsafe due to the risk of dangerously low blood sugar (hypoglycemia). Alcohol use also elevates the likelihood of lactic acidosis.
Averride M 1mg/500mg Tabl...
69
MRP 84
17% off